Lisinopril formulations
US10940177B2 · kind B2 · utility
4Cited by
29References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2020 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Mar 18, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.